Product Highlight - Dienogest (Riliz)

25 Nov 2025
Product Highlight - Dienogest (Riliz)
Release from Endometriosis

• Improves quality of life: Bioequivalent and has potent progestogenic effect in the endometrium, proven effective in shrinking the lesions, alleviating endometriosis-associated pain1

• Better GI tolerance: Lactose-free dienogest that reduces the risk of GI irritation, optimizing absorption among lactose-intolerant patients2

• Better compliance: Up to 28% more affordable vs. other brands2

• SRP: P1,900.50/box of 28

References:
1.
inVentiv Health Clinique, Inc. 2500, rue Einstein, Quebec, Canada G1P 0A2.
2. RilizTM Full Product Information - July 2022.



BIOFEMME, Inc
(The Women’s Health Subsidiary of UNILAB, Inc)

No. 66 United St, Mandaluyong City 1550
Metro Manila
Phone: (+63-2) 8858 1299

Related MIMS Drugs